Happify Health, Almirall Go Live with Digital Solution to Support Psoriasis Patients

Claro was built to improve the mental well-being of people with psoriasis through cognitive behavioral therapy, positive psychology, and mindfulness.

Happify Health and Almirall S.A.’s new digital platform Claro is live and now available to people with psoriasis in Spain, Italy and the United Kingdom. Claro was built to improve the mental well-being of people with psoriasis through cognitive behavioral therapy, positive psychology, and mindfulness.

“At Almirall, we are proud to offer psoriasis patients a wide range of medicines that cover the whole spectrum of the disease, from mild to severe. Claro helps us to fulfill our commitment to people living with psoriasis, providing them with an enhanced solution addressed to their wellbeing, so they can get their lives back,” says Volker Koscielny, MD, Chief Medical Officer of Almirall, in a news release.

“Psoriasis is a significant burden in the daily life of 71 percent of people who suffer from it, according to the National Psoriasis Foundation in the U.K.,” says Theo Ahadome, Senior Vice President of Commercialization at Happify Health. “We are very pleased with the level of engagement we are seeing so far among Claro users, and this partnership gives us the opportunity to study how effective digital programs are at keeping psoriasis patients engaged during treatment for psoriasis and improving their quality of life.”